{
  "issues": [
    "Critical renal function labs (creatinine, BUN, potassium) are missing, preventing eGFR calculation and safe contrast administration assessment.",
    "Body mass index (BMI) is unavailable, which is required for accurate weight‑based iodinated contrast dosing.",
    "No timestamps for any laboratory values are provided; it is unclear how recent the data are.",
    "Agent 2's recommendation to proceed with CT pulmonary angiography after eGFR assessment lacks an immediate alternative imaging pathway while labs are pending.",
    "The suggestion regarding low‑dose CT chest screening is not pertinent to the acute presentation and should not be part of the current protocol selection."
  ],
  "recommendations": [
    "Order STAT serum creatinine, BUN, and potassium (including a basic metabolic panel) to enable eGFR calculation.",
    "Obtain the patient’s current weight and height to calculate BMI for contrast dose determination.",
    "If eGFR is ≥45 mL/min/1.73 m², proceed with CT Pulmonary Angiography (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) using low‑osmolar iodinated contrast, with prophylactic IV isotonic hydration per ACR guidelines.",
    "If eGFR is <30 mL/min/1.73 m², avoid iodinated contrast; use a ventilation‑perfusion (V/Q) scan or MR pulmonary angiography as the primary diagnostic modality for suspected PE.",
    "While awaiting laboratory results, consider bedside transthoracic echocardiography or point‑of‑care ultrasound to assess for right‑heart strain as an interim assessment for PE.",
    "Defer the low‑dose CT chest lung‑cancer screening protocol until the patient meets established screening criteria (age 55–80, ≥30 pack‑year smoking history, former smoker ≤15 years quit).",
    "Document renal safety considerations, obtain informed consent discussing contrast‑associated nephropathy risk, and ensure a post‑contrast hydration plan if contrast is administered."
  ],
  "confidence": 0.92,
  "agent2_confidence": 0.88,
  "timestamp": "2025-09-29T11:33:57.849287Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-29T11:33:50.762017Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "eGFR not available"
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-29T11:33:50.762029Z",
          "priority": "critical",
          "value": null,
          "status": "missing",
          "reason": "Creatinine not available"
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-29T11:33:50.762034Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Missing BUN or creatinine for ratio."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-29T11:33:50.762038Z",
          "priority": "important",
          "value": null,
          "status": "missing",
          "reason": "Potassium not available"
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "eGFR not available",
          "Creatinine not available",
          "Missing BUN or creatinine for ratio.",
          "Potassium not available",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-29T11:33:50.762070Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Critical renal function labs (creatinine, BUN, potassium) are missing, preventing eGFR calculation and safe contrast administration assessment.\",\n    \"Body mass index (BMI) is unavailable, which is required for accurate weight‑based iodinated contrast dosing.\",\n    \"No timestamps for any laboratory values are provided; it is unclear how recent the data are.\",\n    \"Agent 2's recommendation to proceed with CT pulmonary angiography after eGFR assessment lacks an immediate alternative imaging pathway while labs are pending.\",\n    \"The suggestion regarding low‑dose CT chest screening is not pertinent to the acute presentation and should not be part of the current protocol selection.\"\n  ],\n  \"recommendations\": [\n    \"Order STAT serum creatinine, BUN, and potassium (including a basic metabolic panel) to enable eGFR calculation.\",\n    \"Obtain the patient’s current weight and height to calculate BMI for contrast dose determination.\",\n    \"If eGFR is ≥45 mL/min/1.73 m², proceed with CT Pulmonary Angiography (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) using low‑osmolar iodinated contrast, with prophylactic IV isotonic hydration per ACR guidelines.\",\n    \"If eGFR is <30 mL/min/1.73 m², avoid iodinated contrast; use a ventilation‑perfusion (V/Q) scan or MR pulmonary angiography as the primary diagnostic modality for suspected PE.\",\n    \"While awaiting laboratory results, consider bedside transthoracic echocardiography or point‑of‑care ultrasound to assess for right‑heart strain as an interim assessment for PE.\",\n    \"Defer the low‑dose CT chest lung‑cancer screening protocol until the patient meets established screening criteria (age 55–80, ≥30 pack‑year smoking history, former smoker ≤15 years quit).\",\n    \"Document renal safety considerations, obtain informed consent discussing contrast‑associated nephropathy risk, and ensure a post‑contrast hydration plan if contrast is administered.\"\n  ],\n  \"confidence\": 0.92\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Critical renal function labs (creatinine, BUN, potassium) are missing, preventing eGFR calculation and safe contrast administration assessment.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Body mass index (BMI) is unavailable, which is required for accurate weight‑based iodinated contrast dosing.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "No timestamps for any laboratory values are provided; it is unclear how recent the data are.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2's recommendation to proceed with CT pulmonary angiography after eGFR assessment lacks an immediate alternative imaging pathway while labs are pending.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "The suggestion regarding low‑dose CT chest screening is not pertinent to the acute presentation and should not be part of the current protocol selection.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Order STAT serum creatinine, BUN, and potassium (including a basic metabolic panel) to enable eGFR calculation.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain the patient’s current weight and height to calculate BMI for contrast dose determination.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If eGFR is ≥45 mL/min/1.73 m², proceed with CT Pulmonary Angiography (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) using low‑osmolar iodinated contrast, with prophylactic IV isotonic hydration per ACR guidelines.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If eGFR is <30 mL/min/1.73 m², avoid iodinated contrast; use a ventilation‑perfusion (V/Q) scan or MR pulmonary angiography as the primary diagnostic modality for suspected PE.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "While awaiting laboratory results, consider bedside transthoracic echocardiography or point‑of‑care ultrasound to assess for right‑heart strain as an interim assessment for PE.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Defer the low‑dose CT chest lung‑cancer screening protocol until the patient meets established screening criteria (age 55–80, ≥30 pack‑year smoking history, former smoker ≤15 years quit).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document renal safety considerations, obtain informed consent discussing contrast‑associated nephropathy risk, and ensure a post‑contrast hydration plan if contrast is administered.",
        "type": "recommendation",
        "classification": "domain_safe",
        "rationale": "matches safe-whitelist 'obtain informed consent'"
      }
    ],
    "counts": {
      "supported": 11,
      "inferred": 0,
      "domain_safe": 1,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 30045678.0,
        "age": 72.0,
        "hadm_id": 45678912.0,
        "hospital_expire_flag": 0.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "shortness of breath, chest pain, history of diabetes and hypertension",
        "45678912",
        "creatinine_mg_dl",
        "egfr not available",
        "missing bun or creatinine for ratio.",
        "f",
        "medical intensive care unit (micu)",
        "0",
        "creatinine not available",
        "white"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Critical renal function labs (creatinine, BUN, potassium) are missing, preventing eGFR calculation and safe contrast administration assessment.",
      "Body mass index (BMI) is unavailable, which is required for accurate weight‑based iodinated contrast dosing.",
      "No timestamps for any laboratory values are provided; it is unclear how recent the data are.",
      "Agent 2's recommendation to proceed with CT pulmonary angiography after eGFR assessment lacks an immediate alternative imaging pathway while labs are pending.",
      "The suggestion regarding low‑dose CT chest screening is not pertinent to the acute presentation and should not be part of the current protocol selection."
    ],
    "recommendations": [
      "Order STAT serum creatinine, BUN, and potassium (including a basic metabolic panel) to enable eGFR calculation.",
      "Obtain the patient’s current weight and height to calculate BMI for contrast dose determination.",
      "If eGFR is ≥45 mL/min/1.73 m², proceed with CT Pulmonary Angiography (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) using low‑osmolar iodinated contrast, with prophylactic IV isotonic hydration per ACR guidelines.",
      "If eGFR is <30 mL/min/1.73 m², avoid iodinated contrast; use a ventilation‑perfusion (V/Q) scan or MR pulmonary angiography as the primary diagnostic modality for suspected PE.",
      "While awaiting laboratory results, consider bedside transthoracic echocardiography or point‑of‑care ultrasound to assess for right‑heart strain as an interim assessment for PE.",
      "Defer the low‑dose CT chest lung‑cancer screening protocol until the patient meets established screening criteria (age 55–80, ≥30 pack‑year smoking history, former smoker ≤15 years quit).",
      "Document renal safety considerations, obtain informed consent discussing contrast‑associated nephropathy risk, and ensure a post‑contrast hydration plan if contrast is administered."
    ],
    "confidence": 0.92
  }
}